Oxxon Therapeutics

About:

Oxxon Pharmaccines Ltd., an Oxford, UK-based biotech company focused on immunotherapies.

Website: http://www.oxti.com

Top Investors: MVM Life Science Partners, Neomed Management, Gray Ghost Ventures, Quester Capital, NIF Ventures

Description:

Oxxon Therapeutics™ (Oxxon) is a company developing the next generation of innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. To date, the company has built an initial pipeline through its patented Hi-8™ PrimeBoost immunotherapy platform, an approach that allows the rapid development of products to selectively stimulate and enhance potent immune responses against disease. The company has successfully completed phase II clinical programmes in melanoma and hepatitis B and has a third development programme underway in HIV. In addition, the company intends to leverage its enabling platform through partnerships with companies developing therapeutic and preventative vaccine products.